Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case–control study (SAVALO Study)(BMC Infect Dis., (2024), 24, 1434, 10.1186/s12879-024-10303-5)

Following publication of the original article [1], we were notified of an error in the "Results" section of the Abstract. The following sentence "1064 patients were included (cases: 423, controls: 1184)" should read "1607 patients were included (cases: 423, controls: 1184)", as it is later reported in the text (see Results section and Table 1). The authors would like to clarify that this correction does not affect the overall results, conclusions, or interpretations presented in the article. The original article has been corrected.